Inogen Inc (NASDAQ:INGN) currently has a daily average trading volume of 223.49K but it saw 1604088 shares traded in last market. With a market cap of 193.17M USD, the company’s current market price of $8.11 came falling about -14.81 while comparing to the previous closing price of $9.52. In past 52 weeks, the stock remained buoying in the range of price level as high as $13.33 and as low as $5.82.
Taking a look at 20-day trading activity of Inogen Inc (INGN) gives us an average price of $10.71, while its current price level is -39.16% below from 52-week high level whereas it is 39.35% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $10.12 while that of 200 days or SMA-200 reads an average of $9.76. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.13% during that period while stretching the period over a month that decreases to 8.01%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 26.11 which implies that the stock is in oversold territory.
JP Morgan downgraded its recommendation for the stock as a “Neutral” from “Overweight” on August 08, 2023 while assigning a price target range of $15-$8.
Over the week, INGN’s stock price is moving -23.99% down while it is -29.36% when we observe its performance for the past one month. Year-to-date it is -11.56% down and over the past year, the stock is showing a downside performance of -11.75%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $92.3M as analysts are expecting the sales for current fiscal year at $350.65M and seeing the company making $373.01M in sales next year. Moreover, analysts are in estimates of $79M for current-quarter revenue.
Currently, Inogen Inc’s total number of outstanding shares is 23.82M with 12.82% of that held by the insiders while 89.04% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -18.84% and return on equity (ROE) at -18.95%. Stock’s beta reads 1.14. Stock has a price to book (P/B) ratio of 1.04 while price to sale or P/S ratio amounts to 0.58. Its return on asset (ROA) is -11.53% on average.
